Current Affairs & MCQs
Latest Questions, Daily Updates & More

MCQs 2026

171.
Which organization is responsible for the manufacturing of the LCA Tejas?
A Defence Research and Development Organisation (DRDO)
B Hindustan Aeronautics Limited (HAL)
C Bharat Electronics Limited (BEL)
D Mazagon Dock Shipbuilders Limited (MDL)
172.
The development of the LCA Tejas is part of India's broader initiative towards:
A Global military alliances
B Indigenous defense manufacturing and self-reliance
C Space exploration
D Cyber warfare dominance
173.
What is the primary benefit of air-to-air refueling for a fighter aircraft like Tejas?
A Increased stealth capabilities
B Enhanced maneuverability in combat
C Extended operational range and endurance
D Improved electronic warfare capabilities
174.
Which aircraft served as the tanker for the LCA Tejas air-to-air refueling demonstration?
A Boeing KC-46 Pegasus
B Airbus A330 MRTT
C Ilyushin Il-78
D Lockheed Martin KC-130J
175.
What significant milestone did the LCA Tejas achieve on April 5, 2026?
A Successful deployment of indigenous air-to-air missile
B Completion of air-to-air refueling demonstration
C Achieving supersonic speed over land
D First operational deployment in a combat zone
176.
What is a key implication of this breakthrough for the future of medicine?
A Increased reliance on traditional surgical methods
B Development of more personalized and precise treatments
C Reduced importance of genetic research
D Focus solely on infectious diseases
177.
The success of this gene therapy trial highlights the potential of CRISPR technology in which field?
A Environmental conservation
B Agriculture
C Medicine and treating genetic disorders
D Materials science
178.
What specific condition did the CRISPR-based gene therapy target in the recent trial?
A Glaucoma
B Cataracts
C Macular degeneration
D Leber congenital amaurosis (LCA)
179.
Which gene editing technology was used in the recent clinical trial for inherited blindness?
A TALENs
B Zinc-finger nucleases (ZFNs)
C CRISPR-Cas9
D RNA interference (RNAi)
180.
What is the primary goal of gene therapy for inherited retinal diseases (IRDs)?
A To slow down the progression of vision loss
B To correct or replace faulty genes responsible for the disease
C To transplant healthy retinal cells
D To improve blood circulation to the eyes